Vaginal progesterone and the vaginal first-pass effect

Area of Science:

• Reproductive endocrinology and pharmacology

Background:

• Systemic administration of progesterone (oral or intramuscular) is common but associated with the first-pass effect.
• The first-pass effect can lead to variable drug concentrations and potential side effects.

Purpose of the Study:

• To review the efficacy and applications of vaginal progesterone administration.
• To highlight its advantages over systemic routes.

Main Methods:

• Review of existing literature on vaginal progesterone.
• Analysis of its pharmacokinetic profile, focusing on the avoidance of the first-pass effect.
• Examination of clinical applications.

Main Results:

• Vaginal progesterone bypasses the hepatic first-pass metabolism, leading to more predictable serum concentrations.
• Common uses include hormone replacement therapy and luteal phase support in assisted reproductive technologies.
• It effectively avoids adverse effects associated with oral progestins and progesterone.

Conclusions:

• Vaginal progesterone is a viable and effective alternative to systemic administration.
• It offers a targeted therapeutic approach with a favorable side-effect profile.
• This route presents a unique solution for various clinical challenges in reproductive medicine.